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Abstract
Introduction: This systematic review examines Lipohypertrophy (LH) in patients presenting with Type 1/2 Diabetes (T1/2DM) 
in relation to education and injection techniques. LH is a condition, which occurs in diabetes individuals at injection sights. The 
most common method used is palpation in detecting LH, however preventing LH can be challenging due to a number of risk 
factors associated with LH.
Method: Seven electronic databases were systematically searched for the most appropriate studies to be included. Articles 
were identified using Critical Appraisal Skills Programme (CASP) for eligibility. Key words were used to search the database. 
A PRISMA-based systematic review was used to identify studies. 
Results: A total of 49 studies were identified for consideration for this review, to consolidate the studies the abstracts were 
examined and from these 8 studies were deemed appropriate. Three themes identified from the studies were selected: Theme 1, 
Risk factors in the development of LH; Theme 2, Patient education influences the development of LH and Theme 3, Do injec-
tion techniques cause LH?
Conclusion: There are number of risk factors associated with the cause of LH. Education plays a key role in the prevention of 
LH although this is not without its limitations. Further selective studies are required in order to establish if there is one stand-
alone factor.
Keywords: Type 1/2 diabetes; Adults; Education; Insulin 
injection techniques; Lipohypertrophy
Introduction
Lipohypertrophy (LH) occurs in subcutaneous tissue 
because of the lipogenic effect of repetitive exposure to insulin [1]. 
The fat cells enlarge and proliferate resulting in thickened tissue, 
forming lumps under the skin. LH is associated with suboptimal 
glycaemic control with Al Hayek reporting a threefold increase of 
LH in patients whose control was above the current national target 
(HbA1c - 7%, 86 mmol/L) compared to those within the target 
range [2]. Insulin injection into an LH lesion attenuates insulin 
action with subsequent excess glucose exposure, glycaemic 
variability and augmented threat of severe hypoglycaemia [3]. 
Recognised risk factors for the development of LH include high 
BMI, frequent needle reuse, ineffective insulin injection site(s) 
rotation, size of rotation area, level of education, and interval of 
insulin exposure [4]. Patient behaviours are important mediators 
in the level of LH detected, with patients reusing sites that are less 
painful or more convenient due to ease of access.
This systematic review examines the relationship between 
lipohypertrophy, injection techniques and education in adults with 
type 2 diabetes
Method
Search strategy 
A thorough systematic literature search was undertaken in 
Ovid, Cochrane, Google Scholar, Cinahl, Embase, PubMed and 
Joanna Briggs Institute. A comprehensive systematic electronic 
database review was undertaken to establish studies containing 
information on T1/2DM adults, education on Injection Techniques 
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(IT) in relation to LH. Once selected articles were retrieved, all 
titles and abstracts were screened, and eligible articles identified 
for full text inclusion. Studies and participants were excluded if 
below 18 years, unwell to participate and/or T2DM patients who 
could not partake in an educational session. In order to select 
the studies for this review two valid methodological was used; 
PRISMA (Figure 1) and the Critical Appraisal Skills Programme 
(CASP) tool [5,6]. 
Figure 1: PRISMA Flow Diagram (From: Moher D, Liberati A, 
Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred 
Reporting Items for Systematic Reviews and Metaanalysis).
Quality Assessment
All 8 studies were identified for inclusion based on their 
content and study quality of each paper. Both randomised and 
cohort models within the CASP tool were used. 
Ethical Considerations
There was no discrimination regarding the choice of study 
papers or its contents in relation to religion, gender, ethnicity of its 
subjects or country.
Results and Discussion
 A total number of 49 papers were identified, with 8 studies 
deemed appropriate based on methodological quality. Three themes 
were identified : Theme 1, Risk factors in the development of LH, 
Theme 2, Patient education influences the development of LH and 
Theme 3, Do injection techniques cause LH?
Theme 1 - Risk factors in the development of Lipohypertrophy 
(LH)
Three selected studies 3, 5 and 7 [7-9], all considered risk 
factors to be a key role in the association with the cause of LH.
Lipohypertrophy in these individuals was affected by their 
level of education, the frequency that they changed needles, the 
frequency of changing their injection sites and the timeframe over 
which they had been using insulin. All of the diabetes individuals in 
Study 3 were given training beforehand about how to rotate an area 
by using it exclusively for only 1 week. In spite of this, 89 (41.4%) 
of the group insisted on either using the same area, selecting 
an area haphazardly or using a different site at every injection. 
Although study 3 indicated that education, gender, body mass 
index and the length of needle may not impact the development of 
lipohypertrophy, the incidence of lipohypertrophy increased as the 
period of insulin use increased. Moreover, incorrect rotation and 
failure to change needles are two problems recognised as related 
to insulin injection techniques.
Study 5 also identified additional factors which influence 
lipohypertrophy are those who are female, presenting with type 
1 diabetes, higher Body Mass Index (BMI) and aberrations in 
insulin injection rotation. The data suggested that the amount 
of subcutaneous adipose tissue (female sex and BMI) may be 
important for the development of lipohypertrophy. Other factors 
such as age or characteristics of insulin treatment did not contribute 
to the occurrence of lipohypertrophy. The need to change injection 
sites regularly was acknowledged by 119 (78.7%) of outpatients, 
however only 34 (22.7%) followed an organised rotation system. 
The organised rotation group of patients had the lowest incidence 
of lipohypertrophy and the least unstable glycaemic profile. The 
study believed that longstanding incorrect habits promulgate 
the use of lipohypertrophic areas to inject insulin. Such rooted 
habits are difficult to change unless the patient is aware of the 
consequences of injecting insulin into lipohypertrophic areas.
[10] delineated that failing to rotate injection sights is a 
determinant of LH. They also acknowledged that long-standing 
habits had occurred and were difficult to change or alter. NICE 
guidelines suggested that the injection sites should be abdomen, 
outer thigh, buttocks, and arm [11]. It was reported that accessing 
some of these areas is difficult especially if the patient is in public 
or suffers with dexterity such as arthritis [12].
Surucu (Study 7) [7] investigated the frequency of 
lipohypertrophy and showed that the frequency of lipohypertrophy 
had decreased in Turkey over a 10-year period. It was considered 
the decrease stemmed from the patients’ preference for shorter 
needles (4 mm and 5 mm). 
Regarding insulin injection technique, lipohypertrophy was 
shown to be more common in patients who received education on 
insulin administration from the doctor (65.8%) compared to a nurse. 
Data showed that the frequency of lipohypertrophy was higher 
in patients who failed to alternate the injection site (systematic 
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rotation) 209 (48%) compared to those who did not perform intra-
site rotation 159 (63.5%). Needle length, site rotation, changing 
of needle, injection site used and education were all determining 
factors affecting the development of lipohypertrophy. Needle length 
and type of insulin used in individuals with type 2 diabetes revealed 
that the likelihood of lipohypertrophy was significantly lower in 
patients using 5 mm needle (31.1%). In addition, the prevalence 
of lipohypertrophy was significantly higher in patients who failed 
to systematically alternate the injection site 209 (48.2%). Results 
discovered that lipohypertrophy was significantly higher in the 
obese patients. In addition, lipohypertrophy was more common in 
patients experiencing hypoglycaemia 168 (61.5%).
Young, et al. support this by also identifying that injection of 
insulin is not without risks including the risk of injecting into the 
Intramuscular (IM) tissue [13]. This has been previously identified 
as promoting Pharmacokinetics (PK) and Pharmacodynamics 
(PD) distortion of the insulin, promulgating poor glycaemic 
control and possible long-term complications such as renal failure. 
Understanding the rational for site rotation and the metabolic 
implications due to the lack of rotation needs to be consistently 
addressed. In addition, Hauner, et al. also support the findings that 
those who received education from medical personnel (doctor) 
are more likely to have LH episodes than those educated by the 
specialist nurse(s) [14].
Theme 2 -Patient education influences the development of 
Lipohypertrophy (LH)
Three studies 1, 2 and 8 [15-17] were concerned with 
the education of the administration of insulin injections and its 
connection with LH. Clapham, et al. carried out a Cohort study with 
75 insulin-injecting patients with the use of an intensive education 
program [15]. Lipohypertrophy sites decreased significantly by 
the end of the study, either disappearing completely or shrinking 
by approximately 50% from its original diameter. Injections into 
lipohypertrophy decreased by more than 75% by the end. Most 
patients were not correctly rotating injection sites at the beginning. 
However, by the end of the followed up period (3-6 months) the 
rotation of sites had increased 5-fold. 
Clapham, et al. [16] also established that, although 
approximately 33.3% of patients used the 4 mm needle from the 
outset of the study, by the end of the study, virtually all used the 
4 mm needle. With this, the mean HbA1c improved by more than 
4mmol/L and there were significantly lower levels of unexpected 
hypoglycaemia and glucose variability. Total daily doses of insulin 
dropped by an average of 5.6 IU by study end. 
[16] carried out a randomised controlled study on 109 patients 
in order to establish the impact of injection technique education on 
insulin-treated patients with clinically observed lipohypertrophy. 
The intervention group (n = 53) showed a significant decrease 
in total daily dose of insulin (average at baseline: 54.1 IU) at 3 
months and 6 months, attaining > 5 IU after a 6- month timeframe. 
There were significant decreases in HbA1c (up to 0.5%) at 3 and 6 
months in both groups, with no significant differences between the 
groups. A significant number of patients in the intervention group 
improved their injection techniques approximately 50% attained 
this by 3 months contrasted with only a 25% of the control group. 
By 6 months, 66% of intervention patients achieved either ideal 
or acceptable injection techniques, while only 33% was realised 
by the control group. This reduction can not only benefit the 
patient but also reduce the cost implications [18]. By identifying 
the importance of treatment for LH including education in 
Information Technology (IT), isolating the cause of LH is difficult 
to individualise [19]. 
In 2016, Li, et al. [17] carried out a hospital Survey in primary, 
secondary and tertiary settings with a view to visual inspection and 
palpation for diabetes patients over 1-year duration.
This survey demonstrated 308 (58.01%) incidences of 
lipohypertrophy in the injection sites of diabetes patients. The 
lipohypertrophy was associated with the insulin injection duration 
and the injection interval with 82.33% in the primary care settings 
87.08% in secondary care settings. Evidence indicated that patients 
with lipohypertrophy in primary care settings were the oldest and 
reluctant to accept guidance/standardisation of insulin injection. 
The acceptance rate was the lowest consequently. Collectively all 
3 studies identified positive results from IT education whether this 
be from a nurse or GP, despite style of education. 
Theme 3 -Do injection techniques cause Lipohypertrophy 
(LH)? 
Berard, et al. 2014 (Study 4) [20] and Frid, et al. 2002 (Study 
4) [21] both considered Injection Techniques (IT) and impact on 
LH.  
The study consisted of 503 participants from 55 centres 
across Canada. Patients and healthcare professionals at each centre 
completed a separate survey regarding injection technique. 503 
individuals (52.9% male, 47.1% female) from 55 centres across 
Canada participated in the study. Of this group, 25% had type 1 
diabetes and 75% had type 2 diabetes. European/Caucasian was 
the group most highly represented (80.2%); Asian (8.1%), Afro-
Caribbean, First Nations and other ethnic groups composed the 
remaining study population.
Of the individuals studied, 49.9% were taking insulin alone, 
and 40.3% of subjects used a combination of insulin and oral 
antihyperglycemic agents to treat their diabetes. The mean length 
of time on insulin was 7.8 years. The remainder of the study group 
(9.8%) used combinations of oral antihyperglycemics, insulin 
and GLP-1 receptor agonists to treat their diabetes. Participants 
injected insulin with a syringe, pen or insulin pump. Of the study 
group, only 2.6% injected using a syringe, with 93.8% injecting 
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using an insulin pen. The remainder of the group used either an alternative device for injection or a combination of devices.
Overall, 402 (80.4%) of participants injected into the abdomen,78 (15.6%) into the thigh, 19 (3.8%) into the arm, 73 (14.6%) into 
the buttocks and 19 (3.8%) into another area of the body. Study subjects were asked to describe their injection technique by indicating 
whether or not they used a skin lift (“Pinch-up”) and to describe the angle used to insert the needle for injection. Pinch-up method: 
abdomen = 196 (43.5%); thigh = 98% (51.0%); arm = 66 (48.9%); buttock = 25 (36.8% and another area = 5 (26.3%) (Table1).
Table 1: Characteristics of studies, sample size, and findings.
Study 
Paper
Author Country Type of Study 
Study 
Setting
Study Partici-
pants / Sample 
size 
Characteristics 
of education 
intervention.
Follow-
up strat-
egies
Results/Findings/Outcome
1
Clap-
ham, 
et al. 
(2017)
United 
Kingdom 
(UK)
Prospective 
Study over 
(Cohort 
study)
Clinical 
settings
75 insulin-
injecting 
patients. 
Interventions in-
cluded the use of 
an intensive edu-
cation program 
and a switch 
to a 4 mm pen 
needle.
Fol-
lowed up 
for 3–6 
months
All injection sites Lipohyper-
trophy sites decreased signifi-
cantly by the end of the study, 
either disappearing completely 
or shrinking by approximately 
50% from its original diameter. 
Injections into lipohypertrophy 
decreased by more than 75% by 
the end. Most patients were not 
correctly rotating injection sites 
at the beginning but by the end 
most were, by a 5-fold margin. 
Only 1/3 of our subjects used 
the 4 mm needle at the begin-
ning of the study; however, 
virtually all did by study end. 
The mean HbA1c improved by 
more than 4 mmol/L and there 
were significantly lower levels 
of unexpected hypoglycaemia 
and glucose variability. Total 
daily doses of insulin dropped 
by an average of 5.6 IU by 
study end.
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2
Cam-
pions, 
et al. 
(2017)
France
Randomised 
Controlled 
Study
Clinic 
setting
109 patients. 
53 in the 
intervention, 
56 controlled. 
79(72.5%) 
men. 58 
(53.8%) had 
Type 1. Age 
range 18-75 
inclusive.
Impact of injec-
tion technique 
education, in-
cluding use of a 
4-mm. pen nee-
dle on insulin-
treated patients 
with clinically 
observed Lipo-
hypertrophy
Follow 
up in 3 
and 6 
months
The intervention group (n = 53) 
showed a significant decrease of 
total daily dose of insulin (aver-
age at baseline: 54.1 IU) at 3 
months and 6 months, reaching 
just over 5 IU after 6 months. 
No significant decreases be-
tween the groups. There were 
significant decreases in HbA1c 
(up to 0.5%) at 3 months and 6 
months in both groups, with no 
significant differences between 
the groups. A significant number 
of patients in the intervention 
group improved their injection 
techniques about half achieved 
this by 3 months versus only a 
quarter of the controlled group. 
By 6 months, two thirds of 
intervention patients achieved 
either ideal or acceptable injec-
tion techniques, while only 1/3 
of controlled group did.
3
Kizilci, 
et al. 
(2006)
Turkey
Observa-
tional and 
data study
Hospital 
based 
setting 
- Face 
to face 
contact
215 Diabetics 
using insulin 
for 2yrs + 31 
were Type 1 
184 were Type 
2 women 109 
(50.45%) Men 
106 (44.9%)
Observation 
and palpation 
techniques were 
used in assessing 
lipohypertrophy 
in these diabetic 
patients.
Had 
insulin 
treat-
ment for 
the last 
2 years, 
all using 
pen 
needles
Lipohypertrophy in these indi-
viduals was affected by their 
level of education, the frequen-
cy that they changed needles, 
the frequency of changing their 
injection sites and the amount 
of time they had been using 
insulin. All of the diabetic 
individuals in this study were 
given training beforehand about 
how to rotate an area by using it 
exclusively for only 1 week. In 
spite of this, 89 (41.4%) of the 
group insisted on either using 
the same area, selecting an area 
haphazardly or using a different 
site at every injection. The study 
showed that education, gender, 
body mass index and the length 
of needle did not have an influ-
ence on the development of 
lipohypertrophy. The incidence 
of lipohypertrophy increases 
as the period of insulin use 
increases. In addition, incorrect 
rotation and failure to change 
needles are two problems that 
have been established related to 
insulin injection techniques.
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4
Berard, 
et al. 
(2014)
Canada Survey
Diabetes 
Educa-
tion 
Centre
503 par-
ticipants 267 
(52.9%) male 
237 (47.1% 
female. 
126 (25%) 
Type 1 377 
(75%) Type 
2 European/
Caucasian was 
most highly 
represented at 
404 (80.2%)
Survey regard-
ing injection 
technique (i.e. 
needle length, 
angle of inser-
tion, incidence 
of lipohypertro-
phy, injection 
routine). Health-
care profession-
als at the centres 
also completed a 
survey regarding 
their patients’ 
injection tech-
niques
No fol-
low up
Overall, 404 (80.4%) of 
participants injected into the 
abdomen,78 (15.6%) into the 
thigh, 19 (3.8%) into the arm, 
73 (14.6%) into the buttocks 
and 19 (3.8%) into another area 
of the body. 184 (36.6%) had 
no explicit injection routine, 
whereas 158 (31.4%) injected 
into the same site at the same 
time each day. Study subjects 
were asked to describe their in-
jection technique by indicating 
whether or not they used a skin 
lift (“pinch-up”) and to describe 
the angle used to insert the nee-
dle for injection. Overall, 227 
(45.1%) of subjects used pinch-
ups for insulin injection, and 
458 (91.0%) injected at a 90-
degree angle. In subjects who 
used pinch-ups, 102 (20.2%) 
released the skin before the 
end of injection, 210 (41.8%) 
released the skin directly after 
injection, 120 (23.8%) released 
the skin less than 5 seconds 
after injection and 71 (14.2%) 
did not know their injection 
techniques. Most common 
injection site abdomen by 371 
(73.7%). There are 2 discrete 
areas (e.g. left thigh, right 
thigh); 470 (93.5%) of subjects 
used both areas for injecting 
insulin, and 445 (88.5%) rotated 
injections within the same site. 
Lipohypertrophy is one of the 
major complications, injec-
tion routines with patient- and 
educator-observed lipohyper-
trophy. Overall, 124 (24.6%) of 
patients observed lipohypertro-
phy, whereas only 67 (13.3%) 
of diabetes educators observed 
the same complication. Review 
of the completed surveys 9.74% 
of diabetes educators did not 
complete an examination for 
lipohypertrophy. When partici-
pants were asked whether they 
injected into lipohypertrophic 
swellings or lumps, 29 (5.7%) 
indicated that they always in-
jected into these areas, while 87 
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5
Gallego, 
et al. 
(1997)
Spain
Clinical and 
Metabolic-
data
Diabetes 
Unit Uni-
versity 
Hospital
150 partici-
pants 57(38%) 
male 93 (62%) 
female 113 
(75%) Type 
1 37 (24%) 
Type 2 diabetic 
patients.
Insulin-treated 
diabetes of at 
least one year’s 
duration, type of 
insulin therapy 
were evaluated, 
Injection sites 
and systematised 
rotation of injec-
tion site were 
also assessed.
No fol-
low up
Patients who are Female, Type 
I diabetics, higher body mass 
index (BMI) and missing rota-
tion of injection sites were all 
identified as independent risk 
factors for the presence of lipo-
hypertrophy. The data suggest 
that the amount of subcutane-
ous adipose tissue (female sex 
and BMI) may be important for 
the development of lipohyper-
trophy. Other factors such as 
age or characteristics of insulin 
treatment did not contribute to 
the occurrence of lipohyper-
trophy. The need to change 
injection sites regularly was 
acknowledged by 119 (78.7%) 
of outpatients, however only 34 
(22.7%) followed an organised 
rotation system. The organ-
ised rotation group of patients 
had the lowest frequency of 
lipohypertrophy and the least 
unstable glycaemic profile. The 
study believed that longstanding 
incorrect habits perpetuate the 
use of lipohypertrophic areas 
to inject insulin. Such rooted 
habits are difficult to change 
unless the patient is aware of 
the consequences of injecting 
insulin into lipohypertrophic 
areas.
6
Frid, 
et al. 
(2002)
Eu-
rope, 7 
countries 
Sweden, 
Belgium, 
Ger-
many, 
France, 
Italy, 
Spain, 
UK
Clinical 
Study
22 sites 
Clinic 
based
1002 patients 
491(49%) male 
511(50.9%) 
female 562 
(56%) Type 
1 404 (40%)
Type 2
Eligible and 
consenting 
patients entering 
the clinic were 
accessioned. 
Injections were 
performed with 
an insulin pen or 
syringe or both 
and participants 
gave verbal 
consent to par-
ticipate.
No fol-
low up
Nearly 702 (70%) of patients 
inject using a pinch-up injec-
tion technique and this practice 
is associated with improved 
HbA1c. 301 (30%) of patients 
in this study reported having 
lipohypertrophy at any one of 
their injection sites. 380 (38%) 
of patients rotated sites each 
time they injected rapid-acting 
insulin. Less than 501 (50%) of 
patients reported having been 
taught about effective means 
for preventing lipohypertrophy. 
Concurrent nurse evaluation 
found the prevalence to be 27%. 
Independent risk factors for 
lipohypertrophy were found 
to be failure by the patients to 
check injection sites regularly, 
failure to rotate sites and longer 
duration of diabetes.
Citation: Thomas J, Meal A, Adams GG (2019 Relationship between Lipohypertrophy, Injection Techniques and Education in Adults with Type 2 Diabetes: A Systematic 
Review. J Diabetes Treat 4: 1074. DOI: 10.29011/2574-7568.001074
8 Volume 4; Issue 02
J Diabetes Treat, an open access journal
ISSN: 2574-7568
7
Surucu, 
et al. 
(2017)
Turkey Face to face
Clinic - 
hospital 
setting
436 Type 
2 Diabetic 
patients 159 
(36%)Male 
277 (63%) 
Female
Investigate the 
frequency of 
lipohypertrophy 
and the factors 
affecting the 
development of 
lipohypertrophy. 
No fol-
low up
It was determined that the 
frequency of lipohypertrophy 
has decreased in Turkey over 
a 10-years period. It is thought 
the decrease results from the 
patients’ preference for shorter 
needles (4 and 5mm). Consider-
ing insulin injection technique, 
lipohypertrophy was found to 
be more common in patients 
who received education on 
insulin administration from the 
doctor 65.8% as appose to a 
nurse It was determined that the 
frequency of lipohypertrophy 
was higher in patients who 
failed to alternate the injection 
site (systematic rotation) 209 
(48%) and those who did not 
perform intra-site rotation 159 
(63.5%). Needle length, site 
rotation, changing of needle, 
injection site used and educa-
tion were all determined as 
important risk factors affecting 
the development of lipohyper-
trophy. Needle length and type 
of insulin used in individuals 
with type 2 diabetes revealed 
that the likelihood of lipo-
hypertrophy was significantly 
lower in patients using 5 mm 
needle (31.1%). In addition, the 
prevalence of lipohypertrophy 
was statistically significantly 
higher in patients who failed 
to systematically alternate the 
injection site 209 (48.2%). 
Results revealed that lipohyper-
trophy was significantly higher 
in the obese category patients. 
In addition, lipohypertrophy 
was more common in patients 
experiencing hypoglycaemia 
168 (61.5%).
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8 Li, et al. (2016) China Survey
Hospital 
Survey 
in - 
Primary, 
Second-
ary and 
tertiary 
settings
736 patients
Visual in-
spection and 
palpation were 
performed for 
diabetes patients 
with the disease 
duration over 1 
year.
No fol-
low up
This survey shows the inci-
dences of lipohypertrophy in 
the injection sites of diabetes 
patients were 308 (58.01%), and 
the lipohypertrophy was associ-
ated with the insulin injection 
duration and the injection 
interval in the tertiary hospitals; 
87.08% in the secondary hospi-
tals and the risk factors were the 
insulin injection duration and 
the injection area; 82.33% in the 
primary hospitals and the risk 
factors were the diabetes dura-
tion and the injection interval. 
Patients with lipohypertrophy in 
primary hospitals were the old-
est and they were reluctant to 
accept guidance standardisation 
of insulin injection so that the 
acceptance rate was the lowest. 
The survey also noted patients 
with lipohypertrophy who 
use the needles repeatedly the 
insulin needles cost was lower 
than patients without lipohyper-
trophy who use the needles 
once. Education and content 
was the same in different grade 
hospitals. Primary and second-
ary hospitals lack of profes-
sional nurse, education cannot 
be adjusted based on local 
conditions, using lecture form 
to save manpower cost and 
time. Tertiary hospitals set up 
education clinics, can provide 
full-time education.
The study also found incorrect injection site along with 
poor technique, can lead to modified insulin absorption, leading to 
complications such as hypoglycaemia. Other studies support this 
by reporting that insulin absorption from LH sites is erratic causing 
inadequate glucose control 22-23. The pinch-up technique has also 
been identified in this study as a good IT, as it enables the patient to 
inject into the subcutaneous tissue as appose to the intramuscular. 
Using the pinch-up technique, individuals found their HbA1c was 
lower, also those leaving the needle in place longer than 10 seconds 
had an even lower HbA1c reading as appose to those that removed 
it before 10 seconds. 
Berard [20] and Frid [21] are both in agreement. [22] 
examined 1002 patients 491(49%) male, 511(50.9%) female with 
562 (56%) Type 1 and 404 (40%)Type 2 participants. Nearly 702 
(70%) of patients injected using a pinch-up injection technique 
and this practice was associated with improved HbA1c. 301 
(30%) of patients reported having lipohypertrophy at any one of 
their injection sites. 380 (38%) of patients rotated sites each time 
they injected rapid-acting insulin. Less than 501 (50%) of patients 
reported having been taught about effective means for preventing 
lipohypertrophy. Independent risk factors for lipohypertrophy were 
found to be failure by the patients to check injection sites regularly, 
failure to rotate sites and longer duration of diabetes.
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Conclusion
This systematic review sought to examine the relationship 
between lipohypertrophy, injection techniques and education in 
adults with type 2 diabetes. The evidence underlined that education 
for both staff and patients plays a key role in the identification 
of LH along with providing vital information on IT and the risk 
factors associated with immediate risk of LH development. It would 
appear from these studies that there is not one single main cause 
of LH but a variety of risk factors associated with the development 
of LH. It would be justified to suggest that further research into 
individual risk factors is required. 
The evidence has also underlined that education could 
potentially be the first risk factor of the development of LH, as 
patients first receive their information regarding insulin injections 
from a healthcare profession e.g. Doctor or Nurse. Therefore, 
investigations to establish the health care professionals’ training 
would be an advantage to provide a clearer picture of the 
information patients receive and understand. More detailed studies 
would be beneficial based on type, style, participants’ age along 
with who delivers the education and their background knowledge. 
In conclusion different countries underestimate the 
importance of identifying LH and their long-term risk associated 
to their health suggesting additional more in depth trials are 
required. 
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